InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Mayo Stephen, Directeur. Officer active across 2 companies, notably Sarepta Therapeutics, Inc.. Aggregated, 10 filings have been published. Split: 0 buy · 4 sells. Total volume traded: €592k. History available since 16 November 2021. The latest transaction was disclosed on 12 March 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Mayo Stephen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
7,239 shares@ US$17.0219.3% of flowCommon StockSEC:0001193125-26-106701:0
2,383 sharesCommon StockSEC:0000950170-25-037525:0
3,135 shares@ US$122.9679.7% of flowCommon StockSEC:0000950170-24-027497:0
1,846 shares0Common StockSEC:0000950170-24-026614:0
10,000 shares@ US$4.2855100.0% of flowCommon StockSEC:0001593968-23-001153:0
1,523 shares0Common StockSEC:0001209191-23-017394:0
858 shares@ US$109.9220.3% of flowCommon StockSEC:0001209191-22-058283:0
35,328 shares0Common StockSEC:0001737287-22-000053:0
2,953 shares0Common StockSEC:0001209191-22-017713:0
4,292 shares0Common StockSEC:0001209191-21-065315:0
10 of 10 declarations
About Mayo Stephen
Mayo Stephen is Director at Sarepta Therapeutics, Inc. and Allogene Therapeutics, Inc. The record shows 10 filings in total, and across the 10 sampled recent filings the transactions are all sales, totaling EUR 591523, from 2021-11-17 to 2026-03-13. The most common transaction nature is Attribution.
